Investigators reported that women with multiple sclerosis in Sweden had substantially fewer live births than would be expected from national rates. The cohort recorded 3,577 children across the study window. Shortfall compared with national expectation amounted to roughly 1,200 births — about a 25% deficit (observed-to-expected ratio 0.75, 95% CI 0.72 to 0.77). The authors observed similar magnitudes of difference in the early and late study periods, and statistical testing did not show a population-by-period interaction that would indicate change over time (p=0.31).
The study team linked the Swedish MS Register to the National Patient Register and the Medical Birth Register, and used national population counts from Statistics Sweden to derive rates. The source reported 10,452 women with MS contributing 76,989 woman-years. The manuscript did not report individual-level demographic distributions beyond the aggregate woman-years and total births; specific covariate distributions and treatment exposure details were not provided in the abstract. The authors noted that individual-level register data cannot be shared publicly under Swedish law, and that analysis code is available on reasonable request from the corresponding author.
Data indicated the overall observed-to-expected ratio for births in the MS cohort was 0.75 (95% CI 0.72 to 0.77). When split into time periods, observed-to-expected ratios were 0.73 (95% CI 0.68 to 0.79) for 2004–2008 and 0.70 (95% CI 0.65 to 0.75) for 2019–2022. Those period estimates document a persistent deficit in live births among women with MS across the study timeframe. The investigators reported that standardised rate ratios were below 1 in every annual comparison, with a median standardised rate ratio of 0.77 across years.
To account for confounding by age and geography, the study estimated adjusted risk ratios using a matched comparison sample. Age- and region-adjusted risk ratios ranged from 0.75 to 0.86 across the prespecified periods, and the distribution of those ratios showed heterogeneity across periods (heterogeneity p=0.020). The ratios were closest to unity in the 2009–2013 period. The source did not provide additional adjustment covariates or model specifications in the abstract; therefore, further modeling details were not reported here.
Annual standardised rate ratios remained below 1 every year in the analysis; the median across years was 0.77. That year-by-year consistency appears to reflect a stable relative deficit in births among women with multiple sclerosis when compared with the general Swedish female population. The authors did not report annual counts of births by age strata in the abstract; those data may be present in the full text or supplementary materials, which interested readers can request via the corresponding author.
The study was approved by the Regional Ethical Review Board in Stockholm, with an amendment approved by the Swedish Ethical Review Authority. The ethical review board waived the requirement for individual informed consent because the analysis used pseudonymised register data. The authors declared funder information (Swedish Research Council) and conflicts of interest for some coauthors; one author reported no competing interests.
Key limitations documented in the source include that individual-level register data cannot be publicly shared under Swedish law and that no study protocol was registered or published. The abstract did not report granular clinical variables such as disability status, parity history, fertility treatments, or disease-modifying therapy exposure; these items were not described in the abstract and therefore cannot be summarized here. Analysis code is available from the corresponding author upon reasonable request.
Unanswered questions left by the reported results include whether the persistent birth deficit is driven primarily by patient choice, biological infertility, disease severity, or treatment-related concerns — the source did not provide causal attribution in the abstract. The investigators did not report prospective protocol registration, and that absence was explicitly stated. Researchers seeking individual-level data must apply to Swedish authorities (Socialstyrelsen, Statistics Sweden, and the Swedish MS Registry) and obtain ethical approval before access can be granted.